Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling

被引:17
|
作者
Bogaards, JJP [1 ]
Freidig, AP [1 ]
van Bladeren, PJ [1 ]
机构
[1] TNO, Nutr & Food Res, Div Toxicol, NL-3700 AJ Zeist, Netherlands
关键词
isoprene; metabolism; cytochrome P450; glutathione S-transferase; epoxide hydrolase; PBPK modelling;
D O I
10.1016/S0009-2797(01)00276-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was designed to explain the differences in isoprene toxicity between mouse and rat based on the liver concentrations of the assumed toxic metabolite isoprene diepoxide. In addition, extrapolation to the human situation was attempted. For this purpose, enzyme kinetic parameters K-m and V-max were determined in vitro in mouse, rat and human liver microsomes/cytosol for the cytochrome P450-mediated formation of isoprene mono- and diepoxides, epoxide hydrolase mediated hydrolysis of isoprene mono- and diepoxides, and the glutathione S-transferases mediated conjugation of isoprene monoepoxides. Subsequently, the kinetic parameters were incorporated into a physiologically-based pharmacokinetic model, and species differences regarding isoprene diepoxide levels were forecasted. Almost similar isoprene diepoxide liver and lung concentrations were predicted in mouse and rat, while predicted levels in humans were about 20-fold lower. However, when interindividual variation in enzyme activity was introduced in the human model, the levels of isoprene diepoxide changed considerably. It was forecasted that in individuals having both an extensive oxidation by cytochrome P450 and a low detoxification by epoxide hydrolase, isoprene diepoxide concentrations in the liver increased to similar concentrations as predicted for the mouse. However, the interpretation of the latter finding for human risk assessment is ambiguous since species differences between mouse and rat regarding isoprene toxicity could not be explained by the predicted isoprene diepoxide concentrations. We assume that other metabolites than isoprene diepoxide or different carcinogenic response might play a key role in determining the extent of isoprene toxicity. In order to confirm this, in vivo experiments are required in which isoprene epoxide concentrations will be established in rats and mice. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 265
页数:19
相关论文
共 50 条
  • [31] Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling
    Zhang, Hongyan
    Bu, Fengjiao
    Li, Lei
    Jiao, Zheng
    Ma, Guo
    Cai, Weimin
    Zhuang, Xiaomei
    Lin, Hai-Shu
    Shin, Jae-Gook
    Xiang, Xiaoqiang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (03) : 331 - 340
  • [32] Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study
    Maass, Christian
    Schaller, Stephan
    Dallmann, Andre
    Bothe, Kathrin
    Mueller, Dennis
    TOXICOLOGICAL SCIENCES, 2023, 192 (01) : 59 - 70
  • [33] Species Extrapolation of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models to Investigate the Developmental Toxicology of Ethanol Using In vitro to In vivo (IVIVE) Methods
    Martin, Sheppard A.
    McLanahan, Eva D.
    Bushnell, Philip J.
    Hunter, E. Sidney, III
    El-Masri, Hisham
    TOXICOLOGICAL SCIENCES, 2015, 143 (02) : 512 - 535
  • [34] Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat
    Chen, Lu
    Ning, Jia
    Louisse, Jochem
    Wesseling, Sebas
    Rietjens, Ivonne M. C. M.
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 116 : 216 - 226
  • [35] Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human
    Strikwold, Marije
    Spenkelink, Bert
    Woutersen, Ruud A.
    Rietjens, Ivonne M. C. M.
    Punt, Ans
    ARCHIVES OF TOXICOLOGY, 2013, 87 (09) : 1709 - 1723
  • [36] Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling
    Louisse, Jochem
    Bosgra, Sieto
    Blaauboer, Bas J.
    Rietjens, Ivonne M. C. M.
    Verwei, Miriam
    ARCHIVES OF TOXICOLOGY, 2015, 89 (07) : 1135 - 1148
  • [37] Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling
    Jochem Louisse
    Sieto Bosgra
    Bas J. Blaauboer
    Ivonne M. C. M. Rietjens
    Miriam Verwei
    Archives of Toxicology, 2015, 89 : 1135 - 1148
  • [39] REDUCED PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR REPAGLINIDE: IMPACT OF OATP1B1 GENOTYPE AND SOURCE OF IN VITRO DATA ON THE PREDICTION OF DRUG-DRUG INTERACTION RISK
    Gertz, Michael
    Saell, Carolina
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM REVIEWS, 2014, 45 : 258 - 258
  • [40] Use of physiologically based kinetic modeling-facilitated reverse dosimetry of in vitro toxicity data for prediction of in vivo developmental toxicity of tebuconazole in rats
    Li, Hequn
    Zhang, Mengying
    Vervoort, Jacques
    Rietjens, Ivonne M. C. M.
    van Ravenzwaay, Bennard
    Louisse, Jochem
    TOXICOLOGY LETTERS, 2017, 266 : 85 - 93